Drug Discovery Informatics Market Size & Growth
The Global Drug Discovery Informatics Market is expected to grow at a CAGR value of 9.1 percent according to research released by GME. The growing adoption of informatics software and the incidence of chronic diseases will help the market grow exponentially. Browse 151 Market Data Tables and 113 Figures spread through 188 Pages and in-depth TOC on "Drug Discovery Informatics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-drug-discovery-informatics-market-2566 By Solution (Services, Software), By Application (Drug Discovery, Drug Development), By Function (Docking, Library & Database Preparation, Sequencing & Target Data Analysis, Molecular Modeling, Other Functions), By End-User (Contract Research Organizations, Pharmaceutical Companies, Biotechnology Companies, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights u2022tThe increasing use of cloud-based services and the increasing urbanization will propel the market growth. u2022tThe increasing number of CROs will contribute to the growth of the market especially in the Asian region u2022tThe largest market share in 2019 was the software segment. u2022tThe sequencing & target data analysis segment of this market would be the dominating segment as compared to the other functions. u2022tThe major players competing in this market are Jubilant Life Sciences, CDD, IBM, Accenture, Dassault Systu00e8mes, Evotec Ag, Infosys Limited, Cognizant, Albany Molecular Research, Selvita, GVK Biosciences, IO Informatics, Schru00f6dinger, Certara, Charles River Laboratories International, Clarivate Analytics, Perkinelmer, Eurofins, Scientific Thermo Fisher Scientific, and Openeye Scientific Software, among others. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-drug-discovery-informatics-market-2566 Solution Outlook (Revenue, USD Billion, 2020-2026) u2022tServices u2022tSoftware Function Outlook (Revenue, USD Billion, 2020-2026) u2022tDocking u2022tLibrary & Database Preparation u2022tSequencing & Target Data Analysis u2022tMolecular Modeling u2022tOther Functions Application Outlook (Revenue, USD Billion, 2020-2026) u2022tDrug Discovery u2022tDrug Development u2022tClinical Trials u2022tPreclinical Testing End-User Outlook (Revenue, USD Billion, 2020-2026) u2022tContract Research Organizations u2022tPharmaceutical Companies u2022tBiotechnology Companies u2022tOthers Regional Outlook (Revenue, USD Billion, 2020-2026) North Americat u2022tThe U.S. u2022tCanada u2022tMexico Europe u2022tGermany u2022tUK u2022tFrance u2022tSpain u2022tItaly u2022tRest of Europe Asia Pacific u2022tChina u2022tIndia u2022tJapan u2022tSouth Korea u2022tAustralia u2022tRest of APAC Central & South America u2022tBrazil u2022tArgentina u2022tRest of CSA Middle East & Africa u2022tSaudi Arabia u2022tUAE u2022tRest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: 16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
44 views • 3 slides